Choriocarcinoma (staging)
{"favouriteUrl":"/articles/choriocarcinoma-staging-1/add_favourite?lang=us","favouriteId":13979,"favouriteKind":"article","loginUrl":"/sessions/new?lang=us\u0026return_to=%2Farticles%2Fchoriocarcinoma-staging-1%3Flang%3Dus","unfavouriteUrl":"/articles/choriocarcinoma-staging-1/remove_favourite?lang=us"}
{"favouriteUrl":"/articles/choriocarcinoma-staging-1/add_favourite?lang=us","favouriteId":13979,"favouriteKind":"article","loginUrl":"/sessions/new?lang=us\u0026return_to=%2Farticles%2Fchoriocarcinoma-staging-1%3Flang%3Dus","unfavouriteUrl":"/articles/choriocarcinoma-staging-1/remove_favourite?lang=us"}
The staging system for choriocarcinoma (usually refers to uterine choriocarcinoma) is the FIGO staging system and is as follows 1:
- stage I: disease limited to the uterus
- stage II: disease out of the uterus but limited to the female genital tract
- stage III: metastasis in the lung with or without involvement of female genital tract
- stage IV: all metastasis at other locations
This staging system is much simpler than the system for ovarian cancer staging and endometrial cancer staging.